Ophthalmology and Therapy

Ophthalmology and Therapy (OPHTHALMOL THER, ISSN: 2193-8245) is a fully open access, peer-reviewed international journal dedicated to the rapid dissemination of high-quality clinical and translational research in ophthalmology. Published by Springer Healthcare, the journal serves as a premier platform for advancing the diagnosis, treatment, and management of ocular diseases. Its scope encompasses a broad spectrum of ophthalmic subspecialties, including but not limited to glaucoma, retinal disorders, cataract and refractive surgery, cornea and external disease, uveitis, neuro-ophthalmology, and pediatric ophthalmology. The journal welcomes a variety of article types to meet the needs of both clinicians and researchers, including original research articles, comprehensive reviews, case series, brief reports, and practical clinical commentaries. Of particular note is its emphasis on pragmatic, clinically relevant studies that bridge the gap between laboratory findings and patient care. The target audience primarily comprises ophthalmologists, optometrists, vision scientists, and allied healthcare professionals seeking timely, evidence-based insights. A key distinguishing feature is its open access model, ensuring that all published content is freely and permanently accessible online, thereby maximizing global readership and impact. The journal holds a distinguished position in the field, as reflected in its 2026 Journal Impact Factor of 4.200 and its ranking in the JCR Q1 quartile, placing it among the top-tier ophthalmic publications worldwide. This standing, combined with a rigorous but efficient peer-review process and rapid online publication, makes Ophthalmology and Therapy a vital resource for cutting-edge ophthalmic knowledge and clinical innovation.